Awareness & Advocacy
Nationwide public campaigns, school outreaches, and media partnerships to dispel myths about MS. We advocate for inclusion, disability rights, and government recognition of neuroimmune disorders in Kenya’s health agenda.
Multiple Sclerosis Kenya Foundation (MSKF) is the legally registered, patient-led organisation transforming neural health across Kenya, Sub-Saharan Africa and the continent. We champion early diagnosis, culturally-aware care, and treatment access for people living with Multiple Sclerosis (MS), Neuromyelitis Optica (NMO), and related neuroimmune disorders.
Nationwide public campaigns, school outreaches, and media partnerships to dispel myths about MS. We advocate for inclusion, disability rights, and government recognition of neuroimmune disorders in Kenya’s health agenda.
Free counselling, peer support groups (in-person & virtual), and patient navigation to shorten the diagnostic odyssey. We help families access MRI, neurologists, and disease-modifying therapies.
Collaborations with Kenyatta National Hospital, Aga Khan University, and MSIF to build Africa’s first NMO registry, train clinicians, and generate local epidemiological data that drives equitable policy.
For decades, Multiple Sclerosis was considered rare in Black African populations. Today, we know it is underdiagnosed, not absent. Lack of neurologists, MRI scarcity, and low awareness mean people suffer for years without a name for their symptoms. Neuromyelitis Optica (NMO), which disproportionately affects people of African descent, is often misdiagnosed as optic neuritis or transverse myelitis. MSKF exists to close this gap: we train clinicians to spot red flags, empower patients to self-advocate, and build community-led support networks from Nairobi to rural villages.
“For three years, I was told I had anxiety and ‘spiritual problems’. When I finally met an MSKF-trained neurologist, I got my NMO diagnosis within weeks. The peer group saved my life — I’m no longer alone.”
“As a clinician, the MSKF training transformed how I see neuroinflammatory diseases. I now test for NMO in every case of bilateral optic neuritis.”
Whether you are a person living with MS or NMO, a family member, a neurologist, a researcher, or a donor — you are part of the movement. Together, we ensure no African faces MS alone.